In 2006, results from randomised controlled trials were published regarding decompressive surgery for the treatment of spaceoccupying 'malignant' middle cerebral artery (MCA) infarctions.
Surgery
In 2006, results from randomised controlled trials were published regarding decompressive surgery for the treatment of spaceoccupying 'malignant' middle cerebral artery (MCA) infarctions.
Each of these studies and the pooled analysis provided evidence for a benefit of early hemicraniectomy with respect to mortality after three months. This article focuses on hemicraniectomy as the current treatment of choice for malignant ischaemic brain infarction.
Complete MCA territory infarctions, occasionally with additional ischaemia of the anterior and posterior cerebral artery (ACA and PCA, respectively), are found in 1-10% of patients with supratentorial infarcts. 1 The term 'malignant MCA infarction' was introduced based on the commonly associated serious brain swelling, which usually manifests itself between the second and fifth day after stroke onset. 2 These massive cerebral infarctions are life-threatening events with a uniform natural course and an extremely poor prognosis. 3 The mass effect leads to an increased intracranial pressure (ICP) with further destruction of formerly healthy brain tissue, resulting in midline shifting and possible transtentorial or uncal herniation in the majority of patients (see Figure 1) . 1, 3 A rapid neurological deterioration with a case fatality rate of up to 80% despite maximal treatment was seen in about two-thirds of these patients. 4, 5 Several medical treatment strategies, such as osmotic therapy, steroids, hyperventilation, barbiturates and buffers, have been proposed to reduce cerebral oedema formation and raised ICP, but so far none of these therapeutic strategies has been supported by adequate evidence of efficacy from experimental studies or randomised clinical trials and several reports suggest that these approaches are not only ineffective, but even detrimental.
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Findings from Experimental and Observational Studies
Hemicraniectomy for the treatment of space-occupying stroke is by no means new and dates back to as early as 1935. 8 Results from animal studies revealed that decompressive surgery was significantly associated with a reduction in mortality and infarct size and, moreover, improved regional blood flow and functional outcome. prospective trials comparing decompressive surgery with conservative treatment, some of which used historical control groups, and most control groups consisted of patients who were older, suffered from more severe co-morbidity and were frequently affected by infarctions of the dominant hemisphere. [14] [15] [16] [17] Comparative data from non-randomised clinical studies reported that hemicraniectomy reduced in-hospital mortality from 60-100% (in controls) to 0-29% in surgically treated patients, and long-term mortality from 83-100% to 33%, respectively. 16, 18 A systematic review performed by Gupta and colleges analysed all available data of 138 patients and described an overall mortality rate after hemicraniectomy of 24% after a period of seven to 21 months. 14 Various trials suggested that decompressive surgery reduces a poor outcome and increases favourable or independent functional outcome.
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territory. 17, 21, 22 Other predictors that have been proposed to predict unfavourable outcome are pre-operative midline shift, low preoperative Glasgow Coma Scale (GCS), presence of anisocoria, early clinical deterioration and internal carotid artery occlusion. 23 In the metaanalysis by Gupta et al., age was the only prognostic factor for poor outcome, whereas time to surgery, the presence of brainstem signs prior to surgery or additional infarction of the ACA or PCA territory were not associated with outcome. 14 
Surgical Techniques
The rationale of decompressive surgery is to remove a part of the neurocranium and to provide space to accommodate the swollen brain.
It further aims to normalise intracranial pressure, to avoid ventricular compression, and to revert brain tissue shifts. Moreover, cerebral blood flow shall also be restored, which may allow a better perfusion and tissue oxygenation of still healthy brain to minimise infarct volume. 24, 25 There are two different techniques: external (removal of the cranial vault and duraplasty) or internal (removal of non-viable, i.e. infarcted, tissue)
decompression. The two techniques can be combined. 15, 19 Meanwhile, there is a broad consensus among neurosurgeons about the recommended procedure. External decompressive surgery consists of a large hemicraniectomy and a duraplasty: a large 
Age Limit for Hemicraniectomy
Although the percentage of young patients with malignant MCA infarction is relatively high, more than 60% of patients are over 50 years of age and 40% are over 60 years of age. 1, 16, 37 There are several studies that indicate an unfavourable outcome in elder patients after hemicraniectomy, proposing an age limit between 50 and 60 years. 17, 22, 23 In the analysis from Gupta and colleges, age was the only prognostic factor for a poor outcome. 14 Interpretation of these findings is limited by the fact that in most of these studies older patients were operated significantly later and treated less aggressively than younger patients. The randomised trials do not contribute very much in this issue, because the upper age limit in the three European trials was 55-60 years. In the pooled analysis, there was no statistical difference for the primary endpoint of mRS 0-4 versus 5 and 6 comparing patients older or younger than 50 years; however, the number of patients over 50 years of age was very small. 30 From the data available it is currently impossible to define an age limit after which decompressive surgery should not be performed.
Conclusion
The pooled analysis of the three randomised controlled trials on decompressive surgery for the treatment of malignant MCA infarction provided basic evidence for a significant reduction in mortality after hemicraniectomy. Nevertheless, there remain some clinical and ethical questions that need to be addressed in the future, especially regarding the time-point of surgery, the hemisphere affected and the age of the patient, combined with a parallel discussion about the outcome of the surviving patients and their quality of life. n
